PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals (NASDAQ:ANAC) announced today its financial results for the fourth quarter and year ended December 31, 2010. The net loss for the fourth quarter ended December 31, 2010 was $7.5 million compared to $3.9 million during the same quarter in 2009. The net loss for the year ended December 31, 2010 was $10.1 million compared to $24.8 million for the year ended December 31, 2009. Cash, cash equivalents and short-term investments totaled $78.6 million at December 31, 2010, compared to $14.5 million at December 31, 2009.
